Company Filing History:
Years Active: 2018
Title: **Graciela Noemi Gershon: Innovator in Asymmetric Synthesis**
Introduction
Graciela Noemi Gershon is a talented inventor based in Kfar-Saba, Israel, whose contributions to the field of medicinal chemistry focus on innovative solutions for sodium channel-mediated diseases. Her groundbreaking patent demonstrates her commitment to advancing healthcare through scientific research and innovation.
Latest Patents
Graciela holds one patent for the asymmetric synthesis of funapide. This invention is directed toward the synthesis of funapide, a compound that plays a significant role in the treatment and/or prevention of diseases or conditions mediated by sodium channels, such as pain. This advancement showcases her expertise in chemistry and its applications in medicine.
Career Highlights
Currently, Graciela is associated with Xenon Pharmaceuticals Inc., a company focused on developing innovative therapies to treat serious diseases. Her work has positioned her as a key contributor to the advancements in pharmacology and drug development.
Collaborations
During her career, Graciela has collaborated with esteemed colleagues, including Ronen Ben-David and Jian Chen. These partnerships symbolize her commitment to teamwork and collaborative innovation within the pharmaceutical sector.
Conclusion
Graciela Noemi Gershon stands out as an accomplished inventor dedicated to improving healthcare through her innovative research. With her patent on the asymmetric synthesis of funapide, she continues to influence the field of medicinal chemistry, highlighting the importance of invention in addressing complex health challenges.